UK markets closed
NIKKEI 225
38,405.66 +470.90 (+1.24%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.63 -1.00 (-1.21%) GOLD FUTURES
2,302.50 -55.20 (-2.34%) DOW
37,935.39 -450.70 (-1.17%) Bitcoin GBP
47,905.59 -2,202.79 (-4.40%)
Ionis Pharmaceuticals Inc (ISI.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 08:08PM CEST. Market open.
| Previous close | 38.95 |
| Open | 39.02 |
| Bid | 38.85 x 50000 |
| Ask | 38.89 x 50000 |
| Day's range | 38.53 - 39.02 |
| 52-week range | 31.27 - 48.76 |
| Volume | |
| Avg. volume | 50 |
| Market cap | 4.654B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Ionis Pharmaceuticals (IONS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Can Ionis' (IONS) Wholly-Owned Drugs Cut Dependency on Collabs?
Ionis' (IONS) collaboration revenues enable it to invest in its wholly-owned pipeline. This is expected to enhance Ionis' already diverse revenue streams.
- Zacks
Ionis Pharmaceuticals (IONS) Down 2.8% Since Last Earnings Report: Can It Rebound?
Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
© 2024 Yahoo. All rights reserved.